Analysis, reports, chat and Advanced access use the same Rusaka Markets account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Reported and computed values remain separate; missing values are not converted to zero.
Research path: Interpret Jyothy Labs's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
Calculated from validated daily candles. Descriptive research only.
Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.
IND AS · INR crore
| Metric | 2026 | 2025 | 2024 |
|---|---|---|---|
| Total Liabilities Shareholders' Equity | 2,252.36 | 2,023.88 | 2,400.93 |
| Accumulated Depreciation Total | -421.72 | -377.09 | -316.19 |
| Cash Equivalents | 25 | Not available | Not available |
| Other Liabilities Total | 80.81 | 93.98 | 84.27 |
| Accrued Expenses | 29.61 | 34.52 | 31.22 |
| Common Stock Total | 36.72 | 36.72 | 36.72 |
| Other Current Assets Total | 3.6 | 8.95 | 8.85 |
| Prepaid Expenses | 5.14 | 8.63 | 7.51 |
| Total Assets | 2,252.36 | 2,023.88 | 2,400.93 |
| Current Portof LT Debt/Capital Leases | 25.13 | 24.76 | 24.65 |
| Additional Paid-In Capital | 694.74 | 694.74 | 504.07 |
| Cash | 27.59 | 77.18 | 84.39 |
| Total Equity | 1,588.61 | 1,382.61 | 1,808.31 |
| Retained Earnings(Accumulated Deficit) | 857.15 | 651.15 | 1,268.08 |
| Total Common Shares Outstanding | 36.72 | 36.72 | 36.72 |
| Property/Plant/Equipment Total-Gross | 825 | 747.67 | 663.04 |
| Tangible Book Valueper Share Common Eq | 40.25 | 34.61 | 27.68 |
| Goodwill Net | 105.24 | 105.24 | 786.33 |
| Total Liabilities | 663.75 | 641.27 | 592.62 |
| Total Debt | 51.58 | 61.28 | 50.56 |
| Short Term Investments | 761.69 | 670.91 | 525.54 |
| Cashand Short Term Investments | 814.28 | 748.09 | 609.93 |
| Total Receivables Net | 302.72 | 304.32 | 225.71 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 |
| Accounts Receivable-Trade Net | 256.6 | 274.44 | 201.39 |
| Property/Plant/Equipment Total-Net | 403.28 | 370.58 | 346.85 |
| Total Current Liabilities | 556.49 | 510.77 | 480.54 |
| Total Inventory | 367.29 | 341.44 | 287.2 |
| Accounts Payable | 316.64 | 290.32 | 276.06 |
| Other Currentliabilities Total | 185.11 | 161.17 | 148.61 |
| Total Long Term Debt | 26.45 | 36.52 | 25.91 |
| Intangibles Net | 5.37 | 6.27 | 5.45 |
| Other Long Term Assets Total | 193.47 | 54.53 | 71.05 |
| Note Receivable-Long Term | 51.97 | 75.83 | 52.05 |
| Total Current Assets | 1,493.03 | 1,411.43 | 1,139.2 |
| Capital Lease Obligations | 26.45 | 36.52 | 25.91 |
| Other Equity Total | Not available | Not available | -0.56 |
| Minority Interest | Not available | Not available | 1.9 |
PEG Ratio1.94
Price to Sale Ratio2.56
Debt 5Yr CAGR %-20.89
Operating Margin 12m13.2
Operating Margin 5y Avg13.02
Net Profit Margin 12m11.32
Net Profit Margin 5y11.13
Dividend Yield %1.71
Overall RiskBalanced risk
Board Risk34.77
ConsensusBuy
Consensus score1.91
Analyst opinions11
Strong Sell count0
Sell count1
Hold count2
Buy count3
Strong Buy count5
Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.Only peers present in the company profile payload are displayed.
| Company | Price | Market cap | P/E | Research |
|---|---|---|---|---|
| Hindustan Unilever | INR 2,085 | 4.90 L | 48.32 | — |
| Godrej Consumer Products | INR 1,080.5 | 1.11 L | 54.2 | — |
| Marico | INR 863.9 | 1.12 L | 62.16 | — |
| Dabur India | INR 414 | 73,441.63 | 39.98 | — |
| Cupid | INR 262.55 | 35,304.07 | 271.87 | — |
Source, timestamp and external destination are shown. Provider relevance scores are not available.
Jyothy Labs launches dual-celebrity campaign for Anti-Bacterial EXO range IMPACT Magazine
Yami Gautam, Keerthy Suresh front Jyothy Labs’ New EXO Campaign as brand launches Bio-Enzyme powered range MediaNews4U
Jyothy Labs declares Rs 3.50 dividend at 35th AGM scanx.trade
Price to earnings forward of Jyothy Labs Limited – NSE:JYOTHYLAB TradingView
Price to sales forward of Jyothy Labs Limited – BSE:JYOTHYLAB TradingView
Enterprise value to EBITDA forward of Jyothy Labs Limited – NSE:JYOTHYLAB TradingView
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and Rusaka Markets AI.
Jyothy Labs Limited is an India-based fast-moving consumer goods (FMCG) company. The Company manufactures and markets a variety of products, such as fabric care, household insecticides, personal care, and dishwashing products catering to a diverse range of consumer needs and preferences. The Dishwashing segment includes dish wash bar, gel, liquid, dish wash scrubber, dishwash steel scrubber and dishwash powder. The Fabric Care segment includes fabric whitener, fabric enhancer, fabric conditioner, detergent powder, detergent liquid and bar soap. The Household Insecticides segment includes mosquito repellent coil, liquid, racquet and aerosol. The Personal Care segment includes body soap, toothpaste, deodorants, talcum powder, after shave and hand wash. The Others segment includes laundry services, incense sticks, toilet cleaner and floor cleaner. Through its Fabric Spa brand, the Company also provides laundry and dry-cleaning services.
Jyothy Labs has the symbol JYOTHYLAB and ISIN - INE668F01031.
Jyothy Labs is currently trading at INR 195.90.
Jyothy Labs has a year high of INR 352.15 and a year low of INR 188.00.
Jyothy Labs has a market capitalization of INR 7,544.39 crore.
Jyothy Labs has a P/E ratio of 21.72.
Jyothy Labs has a dividend yield of 1.71%.
Jyothy Labs has revenue of INR 2,944.29 crore, net income of INR 333.19 crore, and EPS of INR 9.08.
Jyothy Labs has a book value of INR 40.25.
Jyothy Labs has a debt-to-equity ratio of NA.
Jyothy Labs has a price-to-book ratio of 4.87 and a price-to-sales ratio of 2.56.
Corporate-action adjustment is provider-defined. Rusaka Markets research and computed indicators are not investment advice.